SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bo Hyun Kim, Youn-Jae Lee, Won Kim, Jung-Hwan Yoon, Eun Uk Jung, Sung Jae Park, Yoon Jun Kim, Hyo-Suk Lee, Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study, Scandinavian Journal of Gastroenterology, 2012, 47, 8-9, 1048

    CrossRef

  2. 2
    Hong-Ying Zhang, Pei-Fu Chen, Jia-Ming Xu, Quan-Min Dai, Feng Xu, Qing-Wang Han, Jian-Jun Wang, Hei-Ying Jin, Separation and purification of Escherichia coli-expressed human thymosin-α1 using affinity chromatography and high-performance liquid chromatography, Protein Expression and Purification, 2011, 77, 2, 140

    CrossRef

  3. 3
    A. Ciancio, M. Rizzetto, Thymalfasin in the treatment of hepatitis B and C, Annals of the New York Academy of Sciences, 2010, 1194, 1
  4. 4
    Hyun Woong Lee, Joung Il Lee, Soon Ho Um, Sang Hoon Ahn, Hye Young Chang, Yong Kwang Park, Sun Pyo Hong, Young Myoung Moon, Kwang-Hyub Han, Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study, Journal of Gastroenterology and Hepatology, 2008, 23, 5
  5. 5
    Yong-Feng Yang, Wei Zhao, Yan-Dan Zhong, Yi-Jun Yang, Ling Shen, Ning Zhang, Ping Huang, Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis, Antiviral Research, 2008, 77, 2, 136

    CrossRef

  6. 6
    Anna S. F. Lok, Brian J. McMahon, Chronic hepatitis B, Hepatology, 2007, 45, 2
  7. 7
    Marina Ali, Nicholas Manolios, Peptide-based therapies for arthritis, Future Rheumatology, 2007, 2, 3, 287

    CrossRef

  8. 8
    R-N. Chien, C-Y. Lin, C-T. Yeh, Y-F. Liaw, Hepatitis B virus genotype B is associated with better response to thymosin α1 therapy than genotype C, Journal of Viral Hepatitis, 2006, 13, 12
  9. 9
    Jing You, Hong-Ying Cheng, Shou-Ming Yan, Yan-Wei Qiao, Jun-Hua Huang, Bao-Zhang Tang, Guo-Bing Wu, Jun-Yan Qu, Rong-Xue Wu, Lin Zhuang, Yong-Liang Ma, A Randomized, Controlled, Clinical Study of Thymosin Alpha-1 Versus Interferon-Alpha in Chinese Patients with Chronic Hepatitis B Lacking Hepatitis B Envelope Antigen, Journal of the Chinese Medical Association, 2005, 68, 2, 65

    CrossRef

  10. 10
    D. Sprengers, H.L.A. Janssen, Immunomodulatory therapy for chronic hepatitis B virus infection, Fundamental & Clinical Pharmacology, 2005, 19, 1
  11. 11
    S. Iino, J. Toyota, H. Kumada, K. Kiyosawa, S. Kakumu, M. Sata, H. Suzuki, E. B. Martins, The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial, Journal of Viral Hepatitis, 2005, 12, 3
  12. 12
    Stephanos J Hadziyannis, George V Papatheodoridis, Emerging treatments in chronic hepatitis B, Expert Opinion on Emerging Drugs, 2004, 9, 2, 207

    CrossRef

  13. 13
    YUN-FAN LIAW, Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2004, 19, S6
  14. 14
    Rong-Nan Chien, Yun-Fan Liaw, Thymalfasin for the treatment of chronic hepatitis B, Expert Review of Anti-infective Therapy, 2004, 2, 1, 9

    CrossRef

  15. 15
    Anneke K Raney, Robert K Hamatake, Zhi Hong, Agents in clinical development for the treatment of chronic hepatitis B, Expert Opinion on Investigational Drugs, 2003, 12, 8, 1281

    CrossRef

  16. 16
    Pascal Lebray, Anaı̈s Vallet-Pichard, Marie-Louise Michel, Hélène Fontaine, Rodolphe Sobesky, Christian Bréchot, Stanislas Pol, Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection, Journal of Hepatology, 2003, 39, 151

    CrossRef

  17. 17
    Murat Saruc, Nuri Ozden, Nurten Turkel, Semin Ayhan, Lynette M. Hock, Isil Tuzcuoglu, Hakan Yuceyar, Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B, Journal of Pharmaceutical Sciences, 2003, 92, 7
  18. 18
    Hari S Conjeevaram, Anna Suk-Fong Lok, Management of chronic hepatitis B, Journal of Hepatology, 2003, 38, 90

    CrossRef

  19. 19
    Andy S Yu, Emmet B Keeffe, Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period, Clinics in Liver Disease, 2003, 7, 3, 551

    CrossRef

  20. 20
    Ewald Hannappel, Thomas Huff, 2003,

    CrossRef

  21. 21
    ROBERT YM CHEN, PAUL V DESMOND, STEPHEN A LOCARNINI, Emerging therapies of hepatitis B and C, Journal of Gastroenterology and Hepatology, 2002, 17,
  22. 22
    CHUTIMA PRAMOOLSINSUP, Management of viral hepatitis B, Journal of Gastroenterology and Hepatology, 2002, 17,
  23. 23
    G. K. K. Lau, A. Nanji, J. Hou, D. Y. T. Fong, W.-S. Au, S.-T. Yuen, M. Lin, H.-F. Kung, S.-K. Lam, Thymosin-α1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase, Journal of Viral Hepatitis, 2002, 9, 4
  24. 24
    Anna S. Lok, E.Jenny Heathcote, Jay H. Hoofnagle, Management of hepatitis B: 2000—Summary of a workshop, Gastroenterology, 2001, 120, 7, 1828

    CrossRef

  25. 25
    H. L.-Y. Chan, J.-L. Tang, W. Tam, J. J.-Y. Sung, The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis, Alimentary Pharmacology & Therapeutics, 2001, 15, 12
  26. 26
    Pietro Andreone, Sirio Fiorino, Carmela Cursaro, Annagiulia Gramenzi, Marzia Margotti, Loriana Di Giammarino, Maurizio Biselli, Rita Miniero, Giovanni Gasbarrini, Mauro Bernardi, Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial, Antiviral Research, 2001, 49, 2, 75

    CrossRef

  27. 27
    Tim Shaw, Stephen Locarnini, Combination Chemotherapy for Hepatitis B Virus, Drugs, 2000, 60, 3, 517

    CrossRef

  28. 28
    George Kk Lau, Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection, Journal of Gastroenterology and Hepatology, 2000, 15,
  29. 29
    Anna S. F. Lok, Francesco Negro, Hepatitis B and D,